<rst>
<header>
	<relations>
			<rel name="purpose" type="rst"/>
			<rel name="elaboration" type="rst"/>
			<rel name="preparation" type="rst"/>
			<rel name="attribution" type="rst"/>
			<rel name="sequence" type="multinuc"/>
			<rel name="same_unit" type="multinuc"/>
			<rel name="joint" type="multinuc"/>
		</relations>
</header>
<body>
<segment id="1" parent="1001" relname="preparation">1. Introduction</segment>
<segment id="2" parent="1002" relname="preparation">The increasing resistances of pathogenic bacteria are one great problem for worldwide health policy ,</segment>
<segment id="3" parent="1002" relname="joint">because it means a threat of humanity .</segment>
<segment id="4" parent="1002" relname="joint">Pathogenic bacteria can be found in human surroundings ,</segment>
<segment id="5" parent="1002" relname="joint">and drinking water may be contaminated with bacteria in developing countries .</segment>
<segment id="6" parent="1006" relname="span">In the last century sufficient antibacterials were available</segment>
<segment id="7" parent="6" relname="purpose">to effectively treat infections with those various bacteria .</segment>
<segment id="8" parent="1008" relname="joint">Beside the standard antibacterials like penicillin , reserve antibiotics have been discovered from natural sources</segment>
<segment id="9" parent="1008" relname="joint">and were resynthesized by industrial companies .</segment>
<segment id="10" parent="1009" relname="joint">However , an abuse and overuse of those antibiotics is one of the reasons for the present crisis with resistant bacteria .</segment>
<segment id="11" parent="1011" relname="preparation">In the case of viral infections , antibiotics are often prescribed .</segment>
<segment id="12" parent="1012" relname="same_unit">In the case of existing sensitivities of bacteria towards standard antibiotics ,</segment>
<segment id="13" parent="1012" relname="same_unit">novel reserve antibiotics have been used in clinics .</segment>
<segment id="14" parent="1014" relname="span">Therefore , bacteria with contact to those antibiotics like Staphylococcus aureus on human surfaces like skin developed early resistances .</segment>
<segment id="15" parent="14" relname="elaboration">A misuse of antibiotics is also present in the mast of poultry .</segment>
<segment id="16" parent="1011" relname="joint">Those antibiotics contaminate the environment by animal excretions .</segment>
<segment id="17" parent="1011" relname="joint">Finally , industrial waste of antibiotic production is pumped into rivers in producing countries like India .</segment>
<segment id="18" parent="1019" relname="span">Moreover , bacteria develop resistance mechanisms</segment>
<segment id="19" parent="18" relname="elaboration">that allow the spread of resistance genes via plasmids , and also between different species .</segment>
<segment id="20" parent="1021" relname="span">One other problem</segment>
<segment id="21" parent="20" relname="elaboration">that contributes to the present antibiotic crisis</segment>
<segment id="22" parent="1022" relname="span">is the fact</segment>
<segment id="23" parent="24" relname="attribution">that pharmaceutical companies recently announced</segment>
<segment id="24" parent="1023" relname="span">that they would no longer invest in the development of novel antibiotics .</segment>
<segment id="25" parent="1025" relname="span">The financial outcome of the development of life style drugs is much better than that of antibiotics .</segment>
<segment id="26" parent="1026" relname="joint">Antibiotics have to be cheap for a use in low-income or developing countries .</segment>
<segment id="27" parent="1028" relname="span">Innovative but vague approaches</segment>
<segment id="28" parent="1029" relname="span">to find novel antibiotics have been an influencing of the bacterial gene expression</segment>
<segment id="29" parent="28" relname="purpose">to modify the bacterial metabolism .</segment>
<segment id="30" parent="1031" relname="span">Such a modified metabolism might lead to novel metabolic products</segment>
<segment id="31" parent="30" relname="elaboration">which have to be identified</segment>
<segment id="32" parent="1030" relname="joint">and tested for their antibacterial properties .</segment>
<segment id="33" parent="1033" relname="span">Methods</segment>
<segment id="34" parent="33" relname="purpose">to alter gene expression may be varied growth conditions or a microbial co-culturing of various bacteria or of fungi and bacteria .</segment>
<segment id="35" parent="1011" relname="joint">Other sources for the identification of novel antibiotics have been plants , marine invertebrates and insects or amphibia .</segment>
<segment id="36" parent="1036" relname="preparation">Isolated antimicrobial peptides from such sources have long been favored .</segment>
<segment id="37" parent="1036" relname="joint">However , they still hamper with various problems like proteolytic instability , short in vivo half-lives , insufficient solubility and a poor bioavailability .</segment>
<segment id="38" parent="1036" relname="joint">Alternative small-molecule antibacterials are rare .</segment>
<segment id="39" parent="1036" relname="joint">They own promising properties for an oral use ,</segment>
<segment id="40" parent="1040" relname="span">and are not expected to show problems</segment>
<segment id="41" parent="40" relname="elaboration">reported for those antimicrobial peptides .</segment>
<segment id="42" parent="1042" relname="span">Presently , such small-molecule antibacterials</segment>
<segment id="43" parent="1043" relname="span">that result from synthetic chemistry are unknown</segment>
<segment id="44" parent="43" relname="purpose">to emerge as a novel antibacterial compound class .</segment>
<segment id="45" parent="1036" relname="joint">We gained access to two novel structurally-related classes of small-molecule antibacterials by the reaction of substituted indoles and thiophene dicarbaldehyde .</segment>
<segment id="46" parent="1036" relname="joint">Therefore , various composed hybrid molecules were yielded from those indoles and benzothiophene .</segment>
<segment id="47" parent="1047" relname="preparation">Hybrid molecules of antimicrobial active antibiotics , or antifungal drugs have recently been reviewed .</segment>
<segment id="48" parent="1048" relname="span">They mostly consist either of two different antibiotics or antifungals</segment>
<segment id="49" parent="48" relname="elaboration">that are connected by a linker like a simple carbon chain .</segment>
<segment id="50" parent="1047" relname="joint">So fluoroquinolone-oxazolidinone hybrids reached clinical trials</segment>
<segment id="51" parent="1047" relname="joint">and novel 1 , 2 , 3-triazole antifungal hybrids with 8-aminoquinoline or dioxolane have recently been reported .</segment>
<segment id="52" parent="1052" relname="span">Our novel compound classes were tested against prominent Gram-positive bacteria</segment>
<segment id="53" parent="52" relname="elaboration">that are associated with severe hospital infections by Staphylococcus and Enterococcus strains .</segment>
<segment id="54" parent="1047" relname="joint">We identified first lead compounds with promising activities</segment>
<segment id="55" parent="1047" relname="joint">and confirmed the in vitro results first in the in vivo studies for selected derivatives .</segment>
<group id="1000" type="span" />
<group id="1001" type="span" parent="1000" relname="span"/>
<group id="1002" type="multinuc" parent="1001" relname="span"/>
<group id="1005" type="span" parent="1002" relname="joint"/>
<group id="1006" type="span" parent="1007" relname="preparation"/>
<group id="1007" type="span" parent="1005" relname="span"/>
<group id="1008" type="multinuc" parent="1009" relname="preparation"/>
<group id="1009" type="multinuc" parent="1007" relname="span"/>
<group id="1010" type="span" parent="1009" relname="joint"/>
<group id="1011" type="multinuc" parent="1010" relname="span"/>
<group id="1012" type="multinuc" parent="1011" relname="joint"/>
<group id="1014" type="span" parent="1011" relname="joint"/>
<group id="1018" type="multinuc" parent="1011" relname="joint"/>
<group id="1019" type="span" parent="1018" relname="sequence"/>
<group id="1020" type="multinuc" parent="1018" relname="sequence"/>
<group id="1021" type="span" parent="1020" relname="same_unit"/>
<group id="1022" type="span" parent="1020" relname="same_unit"/>
<group id="1023" type="span" parent="22" relname="elaboration"/>
<group id="1025" type="span" parent="1011" relname="joint"/>
<group id="1026" type="multinuc" parent="25" relname="elaboration"/>
<group id="1027" type="span" parent="1026" relname="joint"/>
<group id="1028" type="span" parent="1027" relname="span"/>
<group id="1029" type="span" parent="27" relname="purpose"/>
<group id="1030" type="multinuc" parent="1028" relname="elaboration"/>
<group id="1031" type="span" parent="1030" relname="joint"/>
<group id="1033" type="span" parent="1011" relname="joint"/>
<group id="1035" type="span" parent="1011" relname="joint"/>
<group id="1036" type="multinuc" parent="1035" relname="span"/>
<group id="1040" type="span" parent="1036" relname="joint"/>
<group id="1042" type="span" parent="1036" relname="joint"/>
<group id="1043" type="span" parent="42" relname="elaboration"/>
<group id="1046" type="span" parent="1036" relname="joint"/>
<group id="1047" type="multinuc" parent="1046" relname="span"/>
<group id="1048" type="span" parent="1047" relname="joint"/>
<group id="1052" type="span" parent="1047" relname="joint"/>
	</body>
</rst>
